WHO’s mpox response aims to reduce disease burden, provides scope for developers GlobalData Sep 4, 2024 There is a huge opportunity for developers and manufacturers to advance novel prophylactic and treatment options, says GlobalData
KM Biologics commences clinical trial of COVID-19 vaccine candidate Reuters Mar 22, 2021 The study is a combined Phase 1 and Phase 2 trial involving 210 subjects to test the vaccine’s safety and ability to trigger an…
